What do we know about COVID-19 media coverage and African stock markets? A time-varying connectedness analysis

被引:0
|
作者
Bossman, Ahmed [1 ]
Teplova, Tamara [2 ]
Umar, Zaghum [3 ,4 ]
机构
[1] Univ Cape Coast, Dept Finance, Sch Business, Cape Coast, Ghana
[2] Natl Res Univ, Higher Sch Econ, Fac Econ Sci, Dept Financial Market Infrastruct, Moscow, Russia
[3] Zayed Univ, Coll Business, Abu Dhabi, U Arab Emirates
[4] Lebanese Amer Univ, Adnan Kassar Sch Business, Beirut, Lebanon
关键词
African stock markets; coronavirus disease; COVID-19; media coverage; public mood; C32; G10; G11; N27; SOCIAL MEDIA; COMMODITIES; SENTIMENT; OIL;
D O I
10.1080/00036846.2024.2322571
中图分类号
F [经济];
学科分类号
02 ;
摘要
In this study, we explore the role of media coverage in the connectedness between African stock markets during the COVID-19 pandemic. Using the time-varying parameter autoregression connectedness metric and the Media Coverage Index (MCI), we analyse return and volatility connectedness between African stocks from January 2020 to October 2022. Our findings reveal that the MCI significantly drives risk transmission and financial market contagion from the global market to African markets. We document a peak in return (volatility) connectedness at 73% (55%) during the height of the pandemic in March 2020. The MCI transmits return shocks to all African stock markets except South Africa and Botswana, and volatility spillovers to all African markets. Our analysis suggests potential diversification attributes for stocks from Ghana, Mauritius, and Nigeria, which are strictly net receivers throughout the pandemic period. These findings have important implications for risk management, asset allocation, and market regulation decisions.
引用
下载
收藏
页数:15
相关论文
共 50 条
  • [21] What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
    Yoo, Jin-Hong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (06)
  • [22] Covid-19: How many variants are there, and what do we know about them?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [23] Editorial: What do we know about COVID-19 implications for cardiovascular disease?
    Wang, Zeyuan
    Tang, Muyun
    Luan, Xiaodong
    Tevaearai Stahel, Hendrik
    Aikawa, Masanori
    Xie, Mingxing
    Ge, Shuping
    Zhang, Shuyang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [24] What do we know about the origin of COVID-19 three years later?
    Gaviria, A. Zapatero
    Martin, R. Barba
    REVISTA CLINICA ESPANOLA, 2023, 223 (04): : 240 - 243
  • [25] Covid-19: What do we know about the late stage vaccine candidates?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 : m4576
  • [26] Covid-19: What do we know about the delta omicron recombinant variant?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 376 : o792
  • [27] CARDIAC TROPONINS AND COVID-19: WHAT DO WE KNOW ABOUT HETEROPHILIC ANTIBODIES?
    Campana, Pasquale
    Forzano, Imma
    Pepe, Marco
    Basile, Christian
    Perillo, Errico Federico
    Ranieri, Alessandro
    Conte, Maddalena
    Parisi, Valentina
    Sibilio, Gerolamo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [28] What Do We Really Know About Pulmonary Thrombosis in COVID-19 Infection?
    Raptis, Constantine A.
    Hammer, Mark M.
    Henry, Travis S.
    Hope, Michael D.
    Schiebler, Mark L.
    van Beek, Edwin J. R.
    JOURNAL OF THORACIC IMAGING, 2020, 35 (06) : 341 - 343
  • [29] Resuscitation in COVID-19 patients: What do we know and what should we do?
    Yilmaz, Ezgi
    Arsava, Ethem Murat
    Topcuoglu, Mehmet Akif
    CARDIOLOGY JOURNAL, 2020, 27 (05) : 656 - 657
  • [30] Pandemic preparedness beyond COVID-19: what we know, what we do, and what we do not
    Pericas, Juan M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (05) : 574 - 575